Neprilysin

Inhibitory Selectivity

Neprilysin Products

Catalog No. Information Product Use Citations Product Validations
S3388New

Sacubitrilat

Sacubitrilat (Sac, LBQ-657) is an active inhibitor of neprilysin (NEP).

S7678

Sacubitril/valsartan (LCZ696)

Sacubitril/valsartan (LCZ696, Sacubitril, Valsartan), consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure. Phase 3.

S4426New

Sacubitril hemicalcium salt

Sacubitril (AHU-377) hemicalcium salt, a component of the heart failure medicine LCZ696, is a potent inhibitor of neprilysin (neutral endopeptidase, NEP).

Catalog No. Information Product Use Citations Product Validations
S3388New

Sacubitrilat

Sacubitrilat (Sac, LBQ-657) is an active inhibitor of neprilysin (NEP).

S7678

Sacubitril/valsartan (LCZ696)

Sacubitril/valsartan (LCZ696, Sacubitril, Valsartan), consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure. Phase 3.

S4426New

Sacubitril hemicalcium salt

Sacubitril (AHU-377) hemicalcium salt, a component of the heart failure medicine LCZ696, is a potent inhibitor of neprilysin (neutral endopeptidase, NEP).